反応式
O.NN.C([O:23][CH2:24][C@H:25]1[O:29][C@@H:28]([N:30]2[CH:38]=[C:36]([CH3:37])[C:34](=[O:35])[NH:33][C:31]2=[O:32])[CH2:27][C@@H:26]1[O:39][N:40]1C(=O)C2=CC=CC=C2C1=O)(C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>C(O)C.ClCCl.[Cl-].[Zn+2].[Cl-]>[NH2:40][O:39][C@@H:26]1[C@@H:25]([CH2:24][OH:23])[O:29][C@@H:28]([N:30]2[CH:38]=[C:36]([CH3:37])[C:34](=[O:35])[NH:33][C:31]2=[O:32])[CH2:27]1参加物
実験手順
Hydrazine monohydrate (7 mL) is added to a suspension of 5′-O-trityl-3′-O-phthalimido-thymidine (2.9 g; ca. 3 mmol nucleoside, contaminated with some Ph3P═O) in ethanol (30 mL), and the solution is heated under reflux for 2 h. The ethanol is removed in vacuo and the resulting mixture is partitioned between CH2Cl2 (100 mL) and aqueous NaCl (50% sat.; 100 mL). The organic phase is separated and concentrated in vacuo to give a colorless foam, which is redissolved in anhydrous dichloromethane (20 mL). A solution of zinc chloride etherate (1 M in Et2O; 30 mL; 30 mmol) is then added. After a few minutes, the product starts to precipitate. After 30 minutes, the solution is diluted with CH2Cl2 (100 mL) and the precipitate removed by filtration. The solids are partitioned between water (20 mL) and CH2Cl2 (20 mL). The aqueous phase is separated and lyophilized. The crude product is purified by reverse phase HPLC(C18, gradient 0-5% acetonitrile in water over 20 minutes) to give 3′-O-amino-thymidine (expected 340 mg; 44% overall) as a colorless foam. 1H-NMR (DMSO-d6; 300 MHz): δ(ppm)=1.77 (d, J=0.7 Hz, 3H); 1.97-2.07 (m, 1H); 2.29 (ddd, J=0.7, 5.9, 13.7 Hz, 1H); 3.50-3.66 (m, 2H); 3.99-4.03 (m, 1H); 4.16-4.20 (m, 1H); 5.08 (t, J=5.1 Hz, 1H); 6.10-6.16 (m, 3H); 7.73 (d, J=1.0 Hz, 1H); 11.27 (br s, 1H). 13C-NMR (DMSO-d6; 75 MHz): a (ppm)=12.3, 35.7, 62.1, 83.7, 83.7, 83.9, 109.5, 136.0, 150.5, 163.7.
後処理
- temperaturethe solution is heated
- temperatureunder reflux for 2 h
- customThe ethanol is removed in vacuo
- customthe resulting mixture is partitioned between CH2Cl2 (100 mL) and aqueous NaCl (50% sat.; 100 mL)
- customThe organic phase is separated
- concentrationconcentrated in vacuo
- customto give a colorless foam, which
- waitAfter a few minutes
- customto precipitate
- additionthe solution is diluted with CH2Cl2 (100 mL)
- customthe precipitate removed by filtration
- customThe solids are partitioned between water (20 mL) and CH2Cl2 (20 mL)
- customThe aqueous phase is separated
- customThe crude product is purified by reverse phase HPLC(C18, gradient 0-5% acetonitrile in water over 20 minutes)
出典と根拠
- ORDレコード
- ord-3e5e00fec8dc4dd383d8489fe62cc1fb
- 出典データセット
- uspto-grants-2009_06
- 特許番号
- US07544794B1
関連ノート
読み込み中…